BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dai Y, Chen D, Xu T. DNA Methylation Aberrant in Atherosclerosis. Front Pharmacol 2022;13:815977. [DOI: 10.3389/fphar.2022.815977] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang A, Zeng W, Hao Y, Zhang H, Wang Q, Sun Y, Quan S, Ding N, Yang X, Sun J, Zhang H, Liu B, Jiao Y, Wu K, Jiang Y. Homocysteine accelerates hepatocyte autophagy by upregulation of TFEB via DNMT3b-mediated DNA hypomethylation.. [DOI: 10.1101/2023.01.30.526165] [Reference Citation Analysis]
2 Wilson HM. The intracellular signaling pathways governing macrophage activation and function in human atherosclerosis. Biochemical Society Transactions 2022. [DOI: 10.1042/bst20220441] [Reference Citation Analysis]
3 Zhang X, Wang C, He D, Cheng Y, Yu L, Qi D, Li B, Zheng F. Identification of DNA methylation-regulated genes as potential biomarkers for coronary heart disease via machine learning in the Framingham Heart Study. Clin Epigenetics 2022;14:122. [PMID: 36180886 DOI: 10.1186/s13148-022-01343-2] [Reference Citation Analysis]
4 Wang Q, Fu S, Li S, Huang X, Wang H, Hashmi MF. Correlation of TET-2 Levels with Disease Evaluation in AMI Patients. Contrast Media & Molecular Imaging 2022;2022:1-6. [DOI: 10.1155/2022/9983071] [Reference Citation Analysis]
5 李 晨. Atherosclerosis Research: Origin, Viewpoint and Development Trend. ACM 2022;12:4934-4950. [DOI: 10.12677/acm.2022.125716] [Reference Citation Analysis]